Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder

Psychological Medicine

Volumn 33, Issue 3, 2003, Pages 511-518

  Roy Byrne, Peter ^a,b,c,d,e,f   Russo, J ^a,b,c,d,e,f   Pollack, M ^a,b,c,d,e,f   Stewart, R ^a,b,c,d,e,f   Bystrisky, A ^a,b,c,d,e,f   Bell, J ^a,b,c,d,e,f   Rosenbaum, J ^a,b,c,d,e,f   Corrigan, M H ^a,b,c,d,e,f   Stolk, J ^a,b,c,d,e,f   Rush, A J ^a,b,c,d,e,f   Ballenger, J ^a,b,c,d,e,f  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIPANIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; PLACEBO;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PERSONALITY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PANIC DISORDER; PATIENT DROPOUTS; PERSONALITY DISORDERS; PERSONALITY INVENTORY; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 19244365493     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291703007402     Document Type: Article

References (32)

1. Ashton, H. (1989). Risks of dependence on benzodiazepine drugs: a major problem of long term treatment. British Medical Journal 298, 103-104.
2. Ballenger, J. C., Pecknold, J., Rickels, K. & Sellers, E. M. (1993). Medication discontinuation in panic disorder. Journal of Clinical Psychiatry 54 (suppl.), 15-24.
3. Bruce, T. J., Spiegel, D. A., Gregg, S. F. & Nuzzarello, A. (1995). Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. American Journal of Psychiatry 152, 1156-1160.
4. Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M. & Sykora, K, (1986). Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315, 854-859.
5. Busto, U. E., Sykora, K. & Sellers, E. M. (1989). A clinical scale to assess benzodiazepine withdrawal. Journal of Clinical Psychopharmacology 9, 412-416.
6. Chambless, D. L., Caputo, G. C., Bright, P. & Gallagher, R. (1984). Assessment of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. Journal of Consulting and Clinical Psychology 52, 1090-1097.
7. Cloninger, C. R., Przybeck, T. R. & Svrakic, D. M, (1991). The Tridimensional Personality Questionnaire: US normative data. Psychological Report 69, 1047-1057.
8. Connor, K. M., Davidson, J. R., Potts, N. L., Tupler, L. A., Miner, C. M., Malik, M. L., Book, S. W., Colket, J. T. & Ferrell, F. (1998). Discontinuation of clonazepam in the treatment of social phobia. Journal of Clinical Psychopharmacology 18, 373-378.
9. Craske, M. G. & Barlow, D. H. (2003). Panic Disorder and Agoraphobia in Clinical Handbook of Psychological Disorders. Guilford Press: New York, NY.
10. Fontaine, R., Chouinard, G. & Annable, L. (1984). Rebound anziety in anxious patients after abrupt withdrawal of benzodizepine treatment. American Journal of Psychiatry 141, 848-852.
11. Hamilton, M. (1983). The assessment of anxiety. In Benzodiazepines Divided (ed. M. R. Trimble), pp. 33-43. John Wiley and Sons, Inc.: New York.
12. Higget, A., Fonagy, P., Toone, B. & Shine, P. (1990). The prolonged benzodiazepine withdrawal syndrome: anxiety or hysteria? Acta Psychiatrica Scandinavica 82, 165-168.
13. Klein, E., Colin, V., Stolk, J. & Lenox, R. H. (1994). Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. American Journal of Psychiatry 151, 1760-1766.
14. Lydiard, R. B., Lesser, I. M., Ballenger, J. C., Rubin, R. T., Laraia, M. & DuPont, R. (1992). A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. Journal of Clinical Psychopharmacology 12, 96-103.
15. Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S. & Rosenbaum, J. F. (1993). Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. American Journal of Psychiatry 150, 1485-1490.
16. Pecknold, J. C., McClure, D. J., Fleuri, D. & Chang, H. (1982). Benzodiazepine withdrawal effects. Progress in Neuropsychopharmacology and Biological Psychiatry 6, 517-522.
17. Pecknold, J. C., Swinson, R. P., Kuch, K. & Lewis, C. P. (1988). Alprazolam in panic disorder and agoraphobia: results from a multicenter trail: III. Discontinuation effects. Archives of General Psychiatry 45, 429-436.
18. Reiss, S., Peterson, R., Gursky, D. M. & McNally, R. J. (1986a). Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behavior Research and Therapy 24, 1-8.
19. Reiss, S., Peterson, R. A., Gursky, D. M. & McNally, R. J. (1986b). Anxiety sensitivity, anxiety frequency and the predictions of fearfulness. Behaviour Research and Therapy 24, 1-8.
20. Rickels, K., Case, W. G., Downing, R. W. & Winokur, A. (1983). Long-term diazepam therapy and clinical outcome. Journal of the American Medical Association 250, 767-771.
21. Rickels, K., Case, W. G., Schweizer, E., Swenson, C. & Fridman, R. B. (1986). Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. Psychopharmacology Bulletin 22, 407-415.
22. Rickels, K., Schweizer, E., Case, G. W. & Garcia-Espana, F. (1988). Benzodiazepine dependence, withdrawal severity, and clinical outcome: effects of personality. Psychopharmacology Bulletin 24, 415-420.
23. Rickels, K., Schweizer, E., Case, W. G. & Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Archives of General Psychiatry 47, 899-907.
24. Roy-Byrne, P. P. & Cowley, D. S. (1994). Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety 1, 151-160.
25. Roy-Byrne, P. P., Dager, S. R., Cowley. D. S., Vitaliano, P. & Dunner, D. L. (1989). Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam. American Journal of Psychiatry 146, 860-865.
26. Schopf, J. (1983). Withdrawal phenomena after long-term administration of benzodiazepines. A review of recent investigations. Pharmacopsychiatria 16, 1-8.
27. Schweizer, E. & Rickels, K. (1998). Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatrica Scandinavica (suppl. 393), 95-101.
28. Schweizer, E., Rickels, K., Case, W. G. & Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Archives of General Psychiatry 47, 908-915.
29. Schweizer, E., Rickels, K., De Martinis, N., Case, G. W. & Garcia-Espana, F. (1998). The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychological Medicine 28, 713-720.
30. Spiegel, D. A., Bruce, T. J., Gregg, S. F. & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? American Journal of Psychiatry 151, 876-881.
31. Tyrer, P. (1988). Dependence as a limiting factor in the clinical use of minor tranquillizers. Pharmacological Therapy 36, 173-188.
32. Tyrer, P., Owen, R. & Dawling, S. (1983). Gradual withdrawal of diazepam after long-term therapy. Lancet i, 1402-1406.